Skip to content

Lifecore Biomedical, Inc. LFCR Free cash flow margin

Discontinued — last reported Q3 '22

Free cash flow margin at other companies

Baxter International logo
Baxter InternationalBAX
3%-2.4pp
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
15.7%-2.1pp
ADMA Biologics logo
ADMA BiologicsADMA
21.2%+1.4pp
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
26.5%+1.5pp
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-26.8%-9.6pp
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-65.7%+269pp

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Calculated from Lifecore Biomedical, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Lifecore Biomedical, Inc.’s 10-K, filed March 20, 2024, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s free cash flow margin?
Lifecore Biomedical, Inc. (LFCR) reported free cash flow margin of -36.4% in Q4 2021.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.